Equity Holdings of Nippon India Pharma Fund
Here is the most recent list of
equity holdings in the Nippon India Pharma Fund's portfolio
as of 31 Jul 2025 . The fund's AUM is 6,891.31 crores, of which equity holdings constitute 99.45%.
| Name of the Equity | Holding Percentage |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 12.22% |
| DIVI'S LABORATORIES LTD. | 7.55% |
| LUPIN LTD. | 5.93% |
| CIPLA LTD. | 5.69% |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.57% |
| Medplus Health Services Ltd | 3.86% |
| Vijaya Diagnostic Centre Ltd | 3.55% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 3.31% |
| Gland Pharma Ltd | 3.12% |
| AJANTA PHARMA LTD. | 3.02% |
| ABBOTT INDIA LTD. | 2.70% |
| Thyrocare Technologies Ltd | 2.63% |
| Dr. Lal PathLabs Ltd | 2.38% |
| Narayana Hrudayalaya Ltd | 2.26% |
| AUROBINDO PHARMA LTD. | 2.22% |
| Zydus Lifesciences Ltd | 2.22% |
| PFIZER LTD. | 1.89% |
| Alkem Laboratories Ltd | 1.86% |
| BIOCON LTD. | 1.77% |
| Sanofi India Ltd | 1.54% |
| IPCA LABORATORIES LTD. | 1.33% |
| TORRENT PHARMACEUTICALS LTD. | 1.30% |
| FORTIS HEALTHCARE LTD. | 1.08% |
| Syngene International Ltd | 1.05% |
| INDOCO REMEDIES LTD. | 0.67% |
| ASTRAZENECA PHARMA INDIA LTD. | 0.66% |
| Orchid Pharma Ltd | 0.42% |